Mitochondria targeting nanoGUMBOS were successfully fabricated based on self-assembly of IR780 GUMBOS with different counter-anions that show promising anticancer effects.

Herein, we report on the role of endocytosis in the selective chemotherpeutic toxicity of rhodamine 6G (R6G) based nanomaterials, i.e., nanoGUMBOS, that are derived from a group of uniform materials based on organic salts (GUMBOS). Evaluation of cellular uptake in the presence and absence of endocytosis inhibitors suggests nanoGUMBOS internalization via clathrin-mediated endocytosis in cancer cells and reveals lack of endocytic internalization in normal cells. Results from characterization of these nanomaterials suggest that endocytic internalization in cancer cells leads to nanoGUMBOS dissociation within the endosomal environment. This ultimately results in selective cytotoxicity of the nanoGUMBOS for cancer cells with no toxicity toward normal cells under examined conditions. Following examination of the selectivity mechanism, in vivo investigations were performed to examine potential therapeutic properties of these nanoparticles. Remarkably, nanoGUMBOS treatment using a mouse xenograft model reduced the tumor volume by 50% suggesting retention of in vitro therapeutic properties in vivo. These results corroborate the selective behavior of nanoGUMBOS and demonstrate their in vivo therapeutic effects, providing further insight into the possible use of these nanomaterials as potential chemotherapeutic agents.

The time has come when it is desirable to look for alternative energy resources to confront the global energy crisis. Consideration of the increasing environmental problems and the possible crisis of fossil fuel availability at record high prices dictate that some changes will need to occur sooner rather than later. The recent oil spill in the Gulf of Mexico is just another example of the environmental threats that fossil fuels pose. This paper is an attempt to explore various bio-resources such as corn, barley, oat, rice, wheat, sorghum, sugar, safflower, and coniferous and non-coniferous species for the production of biofuels (ethanol and biodiesel). In order to assess the potential production of biofuel, in this paper, countries are organized into three groups based on: (a) geographic areas; (b) economic development; and(c) lending types, as classified by the World Bank. First, the total fossil fuel energy consumption and supply and possible carbon emission from burning fossil fuel is projected for these three groups of countries. Second, the possibility of production of biofuel from grains and vegetative product is projected. Third, a comparison of fossil fuel and biofuel is done to examine energy sustainability issues.

No abstract

We report a sensor array approach, based on a novel group of 6-(p-toluidino)-2-naphthalenesulfonate (TNS)-based organic salts, for sensitive and label-free sensing of proteins.

Rhodamine 6G nanoGUMBOS were templated with cyclodextrin to develop size tunable nanodrugs with enhanced cellular uptake and selective chemotherapeutic toxicity.

No abstract

The near-infrared fluorescent (NIRF) dye, IR780, is recognized as a promising theranostic agent and has been widely investigated for imaging, chemotherapeutic, and phototherapeutic applications. However, its poor photostability and nonselective toxicities toward both cancer and normal cells limit its biological applications. Herein, we introduce the use of GUMBOS (a group of uniform materials based on organic salts) developed through counter-anion exchange with IR780 and subsequent nanomaterials (nanoGUMBOS) formed by complexation with cyclodextrin (CD) for enhanced chemo/photothermal therapy. Such CD-based nano-GUMBOS display improved aqueous stability, photostability, and photothermal effects relative to traditional IR780. The examination of in vitro cytotoxicity reveals that CD-based nanoGUMBOS are selectively toxic toward cancer cells and exhibit synergistically enhanced cytotoxicity toward cancer cells upon NIR laser irradiation. Additionally, in vivo NIRF imaging demonstrated selective accumulation of these nanoGUMBOS within the tumor site, indicating tumor-targeting properties. Further in vivo therapeutic study of these CD-based nanoGUMBOS suggests excellent chemo/photothermal antitumor effects. Using these studies, we herein demonstrate a promising strategy, via conversion of IR780 into nanoGUMBOS, that can be used for improved theranostic cancer treatment.